{"version":"1.0","type":"link","title":"TACE and tyrosine kinase inhibitors with or without PD-1 inhibitors as first-line therapy for intermediate-advanced HCC: a multicenter real-world cohort study.","author_name":"Yang XG 외","author_url":"https://prs-insight.online/author/Yang%20XG","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/106792","thumbnail_width":1200,"thumbnail_height":630}